Kewen GONG, Yidu TIAN, Yingjue HE, et al. Recombinant Newcastle disease virus rL-RVG induces ferroptosis of gastric cancer cells through inhibiting Nrf2-GCLC-GPX4 pathway[J]. Journal of Army Medical University, 2024, 46(13): 1485-1493.
DOI:
Kewen GONG, Yidu TIAN, Yingjue HE, et al. Recombinant Newcastle disease virus rL-RVG induces ferroptosis of gastric cancer cells through inhibiting Nrf2-GCLC-GPX4 pathway[J]. Journal of Army Medical University, 2024, 46(13): 1485-1493. DOI: 10.16016/j.2097-0927.202310051.
Recombinant Newcastle disease virus rL-RVG induces ferroptosis of gastric cancer cells through inhibiting Nrf2-GCLC-GPX4 pathway
To investigate whether recombinant Newcastle disease virus (rL-RVG) induces iron death in gastric cancer cells through Nrf2-GCLC-GPX4 pathway.
Methods
2
After human gastric cancer HGC-27 cells were treated with rL-RVG
Newcastle disease virus (NDV) and PBS solution (control group)
respectively
cell proliferation
invasion and migration were detected by CCK-8 assay and Transwell invasion assay and cell scratch test. Ferroptosis accelerator (erastin)
and nuclear factor E2 related factor 2 (Nrf2) accelerator (TBHQ) and inhibitor (ML385) were added respectively as controls. The content of malondialdehyde (MDA) in each treatment group was detected by lipid oxidation kit. The content of reactive oxygen species (ROS) was detected by DCFH-DA fluorescent probe and flow cytometry. Western blotting and immunofluorescence assay were employed to measure the expression levels of Nrf2-GCLC-GPX4 pathway related proteins.
Results
2
Compared with the control group
the survival rate of HGC-27 cells were significantly decreased after rL-RVG and NDV treatment in a dose- and time-dependent manner
and the effect was more significant in the rL-RVG treatment group (
P
<
0.05). The migration and invasion abilities of HGC-27 cells were obviously inhibited in the NDV and rL-RVG treatment groups
and the latter had more notable inhibition than the former. The protein levels of Nrf2
GCLC
SLC7A11 and GPX4 were statistically decreased (
P
<
0.05)
and the contents of MDA and ROS were increased (
P
<
0.05) in the virus treatment groups than the control group
with the increasing or decreasing trend more significant in the rL-RVG group than the NDV group. What's more
the protein levels of SLC7A11 and GPX4 were decreased in the erastin group (
P
<
0.05). Compared with the control group
those of Nrf2
GCLC
SLC7A11 and GPX4 were increased in the TBHQ group and decreased in the ML385 group (
P
<
0.05)
while the contents of MDA and ROS were decreased and increased respectively in the above 2 groups (
P
<
0.05). Compared with the rL-RVG group
the rL-RVG+TBHQ group and rL-RVG+ML385 group had enhanced and reduced protein expressio of Nrf2
GCLC
SLC7A11 and GPX4
respectively (
P
<
0.05)
while the contents of MDA and ROS were in opposite trends (
P
<
0.05).
Conclusion
2
rL-RVG can induce ferroptosis of gastric cancer cells through Nrf2-GCLC-GPX4 pathway
and then inhibit the growth of tumor cells.
关键词
Keywords
references
SUNG H, FERLAY J, SIEGEL R L, et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
HE J, CHEN W Q, LI Z S, et al . China guideline for the screening, early detection and early treatment of gastric cancer(2022, Beijing)[J ] . China Cancer, 2022, 31(7): 488-527. DOI: 10.11735/j.issn.1004-0242.2022.07.A002.
DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J ] . Cell, 2012, 149(5): 1060-1072. DOI: 10.1016/j.cell.2012.03.042.
JIANG X J, STOCKWELL B, CONRAD M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282. DOI: 10.1038/s41580-020-00324-8.
DÄCHERT J, EHRENFELD V, HABERMANN K, et al . Targeting ferroptosis in rhabdomyosarcoma cells[J ] . Int J Cancer, 2020, 146(2): 510-520. DOI: 10.1002/ijc.32496.
SHIN D, KIM E H, LEE J, et al . Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer[J ] . Free Radic Biol Med, 2018, 129: 454-462. DOI: 10.1016/j.freeradbiomed.2018.10.426.
LU J, ZHAO Y N, LIU M T, et al . Toward improved human health: Nrf2 plays a critical role in regulating ferroptosis[J ] . Food Funct, 2021, 12(20): 9583-9606. DOI: 10.1039/d1fo01036k.
LIAN G J, GNANAPRAKASAM J R, WANG T T, et al . Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation[J ] . eLife, 2018, 7: e36158. DOI: 10.7554/eLife.36158..
SONG X H, LONG D X. Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases[J]. Front Neurosci, 2020, 14: 267. DOI: 10.3389/fnins.2020.00267.
HE F, ANTONUCCI L, KARIN M. NRF 2 as a regulator of cell metabolism and inflammation in cancer[J ] . Carcinogenesis, 2020, 41(4): 405-416. DOI: 10.1093/carcin/bgaa039.
WANG X M, WANG Y L, HUANG D M, et al . Astragaloside Ⅳ regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM 2.5 -mediated lung injury in mice[J ] . Int Immunopharmacol, 2022, 112: 109186. DOI: 10.1016/j.intimp.2022.109186..
BURMAN B, PESCI G, ZAMARIN D. Newcastle disease virus at the forefront of cancer immunotherapy[J]. Cancers(Basel), 2020, 12(12): 3552. DOI: 10.3390/cancers12123552.
KAN X J, YIN Y C, SONG C P, et al . Newcastle-disease-virus-induced ferroptosis through nutrient deprivation and ferritinophagy in tumor cells[J ] . iScience, 2021, 24(8): 102837. DOI: 10.1016/j.isci.2021.102837.
BU X F, ZHAO Y H, ZHANG Z J, et al . Recombinant Newcastle disease virus(rL-RVG) triggers autophagy and apoptosis in gastric carcinoma cells by inducing ER stress[J ] . Am J Cancer Res, 2016, 6(5): 924-936. DOI: 2156-6976/ajcr0025130.
ZHANG Z Z, LI Y, GAO S B, et al . Recombinant Newcastle virus rL-RVG inhibits proliferation of human lung adenocarcinoma cell lines[J ] . Basic Clin Med, 2023, 43(10): 1549-1556. . DOI: 10.16352/j.issn.1001-6325.2023.10.1549.
GU R J, XIA Y W, LI P F, et al . Ferroptosis and its role in gastric cancer[J ] . Front Cell Dev Biol, 2022, 10: 860344. DOI: 10.3389/fcell.2022.860344.
SMYTH E C, NILSSON M, GRABSCH H I, et al . Gastric cancer[J ] . Lancet, 2020, 396(10251): 635-648. DOI: 10.1016/S0140-6736(20)31288-5.
MACHLOWSKA J, BAJ J, SITARZ M, et al . Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies[J ] . Int J Mol Sci, 2020, 21(11): 4012. DOI: 10.3390/ijms21114012.
SCHIRRMACHER V. Molecular mechanisms of anti-neoplastic and immune stimulatory properties of oncolytic Newcastle disease virus[J]. Biomedicines, 2022, 10(3): 562. DOI: 10.3390/biomedicines10030562.
MENG Q X, HE J, ZHONG L P, et al . Advances in the study of antitumour immunotherapy for Newcastle disease virus[J ] . Int J Med Sci, 2021, 18(11): 2294-2302. DOI: 10.7150/ijms.59185.
YIN C Y, ZHANG Y, CHEN Z W, et al . rL-IL29 inhibits proliferation and migration of human gastric cancer cell line BGC[J ] . Basic Clin Med, 2020, 40(3): 368-373. DOI: 10.3969/j.issn.1001-6325.2020.03.021.
LI M T, HE Y L, PENG C, et al . Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway[J ] . Oncol Lett, 2018, 16(4): 5006-5012. DOI: 10.3892/ol.2018.9267.
ZHAO Y N, LU J, MAO A K, et al . Autophagy inhibition plays a protective role in ferroptosis induced by alcohol via the p62-Keap1-Nrf2 pathway[J ] . J Agric Food Chem, 2021, 69(33): 9671-9683. DOI: 10.1021/acs.jafc.1c03751.
TANG D L, CHEN X, KANG R, et al . Ferroptosis: molecular mechanisms and health implications[J ] . Cell Res, 2021, 31(2): 107-125. DOI: 10.1038/s41422-020-00441-1.
CHEN P, WU Q B, FENG J, et al . Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis[J ] . Signal Transduct Target Ther, 2020, 5(1): 51. DOI: 10.1038/s41392-020-0149-3..
WEI R R, ZHAO Y Q, WANG J, et al . Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells[J ] . Int J Biol Sci, 2021, 17(11): 2703-2717. DOI: 10.7150/ijbs.59404.
XU J C, TIAN X Y, HAN R, et al . Erianin inhibits oral cancer cell growth, migration, and invasion via the Nrf2/HO-1/GPX4 pathway[J ] . Asian Pac J Trop Biomed, 2022, 12(10): 437-445. DOI: 10.4103/2221-1691.357743.
WANG Y L, YAN S, LIU X M, et al . PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway[J ] . Cell Death Differ, 2022, 29(10): 1982-1995. DOI: 10.1038/s41418-022-00990-5.
URSINI F, MAIORINO M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4[J]. Free Radic Biol Med, 2020, 152: 175-185. DOI: 10.1016/j.freeradbiomed.2020.02.027.
KOPPULA P, ZHUANG L, GAN B Y. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy[J]. Protein Cell, 2021, 12(8): 599-620. DOI: 10.1007/s13238-020-00789-5.
FORCINA G C, DIXON S J. GPX4 at the crossroads of lipid homeostasis and ferroptosis[J]. Proteomics, 2019, 19(18): e1800311. DOI: 10.1002/pmic.201800311.
KAJARABILLE N, LATUNDE-DADA G O. Programmed cell-death by ferroptosis: antioxidants as mitigators[J]. Int J Mol Sci, 2019, 20(19): 4968. DOI: 10.3390/ijms20194968.
Dimethyl fumarate alleviates high-altitude hypoxic acute lung injury by activating the NRF2/SLC7A11 axis to inhibit pulmonary epithelial ferroptosis and regulate macrophage polarization
Accessible chromatin upregulates circadian rhythm transcription factor NPAS2 to promote Ferroptosis Resistance in Gastric Cancer Cells
GenX induces cochlear hair cell injury via System Xc⁻-Gpx4-Fsp1 ferroptosis axis
MiR-21-5p alleviates hyperoxia-induced acute lung injury by inhibiting ferroptosis through the STAT3/P53/SLC7A11 axis
PCBP1-mediated regulation of iron homeostasis suppresses ferroptosis against cadmium-induced neurotoxicity in mouse neuroblastoma cells
Related Author
LIU Ting
GUO Haoran
WANG Liye
HAO Zhiyun
WANG Chengbin
WANG Chi
LI Mianyang
LI Yaping
Related Institution
Graduate Institute, Chinese PLA Medical School
Department of Laboratory Medicine, First Medical Center, Chinese PLA General Hospital
Southwest University Medical Research Institute
Department of Gastroenterology,People’s Hospital of Chongqing Hechuan
Department of Gastroenterology, Chongqing Key Laboratory of Precise Prevention and Treatment of Digestive Malignancies, Daping Hospital, Army Medical University